Renal function alters the association of lipoprotein(a) with cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a prospective cohort study

被引:0
|
作者
Zeng, Guyu [1 ]
Zhu, Pei [1 ]
Yuan, Deshan [1 ]
Wang, Peizhi [1 ]
Li, Tianyu [1 ]
Li, Qinxue [1 ]
Xu, Jingjing [1 ]
Tang, Xiaofang [1 ]
Song, Ying [1 ]
Chen, Yan [1 ]
Zhang, Ce [1 ]
Jia, Sida [1 ]
Liu, Ru [1 ]
Jiang, Lin [1 ]
Song, Lei [1 ]
Gao, Runlin [1 ]
Yang, Yuejin [1 ]
Zhao, Xueyan [1 ]
Yuan, Jinqing [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis,Dept Cardiol, Beijing, Peoples R China
关键词
coronary artery disease; estimated glomerular filtration rate; lipoprotein(a); renal function; CHRONIC KIDNEY-DISEASE; PLASMA LIPOPROTEIN(A); RISK; EVENTS; APOLIPOPROTEIN(A); LEVEL;
D O I
10.1093/ckj/sfae032
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
<bold>Background and hypothesis: </bold>Lipoprotein(a) [Lp(a)] and renal dysfunction are both independent risk factors for cardiovascular disease. However, it remains unclear whether renal function mediates the association between Lp(a) and cardiovascular outcomes in patients undergoing percutaneous coronary intervention (PCI). <bold>Methods: </bold>From a large prospective cohort study, 10 435 eligible patients undergoing PCI from January 2013 to December 2013 were included in our analysis. Patients were stratified into three renal function groups according to their baseline estimated glomerular filtration rate (eGFR) (<60; 60-90; >= 90 ml/min/1.73 m(2)). The primary endpoint was a composite of all-cause death, nonfatal MI, ischemic stroke, and unplanned revascularization [major adverse cardiac and cerebrovascular events (MACCE)]. <bold>Results: </bold>Over a median follow-up of 5.1 years, a total of 2144 MACCE events occurred. After multivariable adjustment, either eGFR <60 ml/min/1.73 m(2) or elevated Lp(a) conferred a significantly higher MACCE risk. Higher Lp(a) was significantly associated with an increased risk of MACCE in patients with eGFR <60 ml/min/1.73 m(2). However, this association was weakened in subjects with only mild renal impairment and diminished in those with normal renal function. A significant interaction for MACCE between renal categories and Lp(a) was observed (P = 0.026). Patients with concomitant Lp(a) >= 30 mg/dl and eGFR <60 ml/min/1.73 m(2) experienced worse cardiovascular outcomes compared with those without. <bold>Conclusion: </bold>The significant association between Lp(a) and cardiovascular outcomes was mediated by renal function in patients undergoing PCI. Lp(a)-associated risk was more pronounced in patients with worse renal function, suggesting close monitoring and aggressive management are needed in this population.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Renal Function Alters the Association of Lipoprotein(a) With Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention: A Prospective Cohort Study
    Zeng, Guyu
    Yuan, Jin-Qing
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B89 - B90
  • [2] Impact of Lipoprotein(a) concentrations on long-term cardiovascular outcomes in patients undergoing percutaneous coronary intervention: A large cohort study
    Cui, Kongyong
    Yin, Dong
    Zhu, Chenggang
    Yuan, Sheng
    Wu, Shaoyu
    Feng, Lei
    Dou, Kefei
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (07) : 1670 - 1680
  • [3] Association of lipoprotein (a) and in-hospital outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Wu, Baoquan
    Zhao, Hanjun
    Liu, Changhua
    Lu, Hao
    Liu, Ruishuang
    Long, Juan
    Zhang, Zhiling
    Zeng, Fanfang
    POSTGRADUATE MEDICINE, 2021, 133 (02) : 195 - 201
  • [4] Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
    Tscharre, Maximilian
    Farhan, Serdar
    Freynhofer, Matthias K.
    Leutner, Michael
    Baumgartner-Parzer, Sabina
    Tentzeris, Ioannis
    Vogel, Birgit
    Tinhofer, Florian
    Rohla, Miklos
    Weiss, Thomas W.
    Huber, Kurt
    Kautzky-Willer, Alexandra
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [5] Association of lipoprotein(a) with platelet aggregation and thrombogenicity in patients undergoing percutaneous coronary intervention
    Zhu, Pei
    Tang, Xiao-Fang
    Song, Ying
    Zhang, Yin
    Gao, Li-Jian
    Gao, Zhan
    Chen, Jue
    Yang, Yue-Jin
    Gao, Run-Lin
    Xu, Bo
    Yuan, Jin-Qing
    PLATELETS, 2021, 32 (05) : 684 - 689
  • [6] Assessing renal function as a predictor of adverse outcomes in diabetic patients undergoing percutaneous coronary intervention
    Mousavi, Farima Sadat
    Bagheri, Babak
    Jalalian, Rozita
    Nabati, Maryam
    Moradi, Amir
    Mousavi, Fatemeh
    Ghadirzadeh, Erfan
    ACTA CARDIOLOGICA, 2024, 79 (07) : 824 - 832
  • [7] Effect of coronary endothelial function on outcomes in patients undergoing percutaneous coronary intervention
    Hamasaki, Shuichi
    Tei, Chuwa
    JOURNAL OF CARDIOLOGY, 2011, 57 (03) : 231 - 238
  • [8] Association between hyperuricemia and outcomes in patients undergoing percutaneous coronary intervention
    Wu, Lei
    Yang, Lan-Ju
    Meng, Xiao-Yan
    Wang, Lan-Hua
    Zhou, Yan-Hong
    Liu, Tao
    Han, Qian-Feng
    Zhang, De-Yong
    Yao, Heng-Chen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 204 : 152 - 153
  • [9] Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
    Chen, Zhihao
    Jiang, Chaohui
    Qu, Huimin
    Liang, Shuang
    Yang, Jian
    Wu, Hui
    He, Chao
    Wang, Xinan
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (06) : 1375 - 1380
  • [10] The Impact of a New STEMI Hotline on Cardiovascular Outcomes in STEMI Patients Undergoing Primary Percutaneous Coronary Intervention: A National Cohort Study
    Bardooli, Fawaz
    Alhashli, Ali
    AlKhaja, Omar Y.
    Faizal, Mohammed
    Abdulmalek, Khaled
    Musameh, Shaikha
    Mallah, Saad I.
    AlKhayat, Mohammed
    Abdulrahman, Abdulkarim
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2022, 34 (03) : 212 - 221